Coverage of "Prostate Cancer" on Cryptosearcher: the stories and the context behind them.
Profound Medical's stock climbed after a trial demonstrated its TULSA procedure outperforms robotic surgery on key quality-of-life measures, including preservation of penile length.
July 25, 2026
